Valeant Posts Upbeat Q1 Results, Lifts Full-Year Forecast

By: via Benzinga
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) reported upbeat results for the first quarter and raised its forecast for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.